; Pfizer has begun to operate in the English generics market through its company Pharmacia Generic, whose generic initial portfolio includes eight molecules amisulpride, escitalopram, ropinirole, amlodipine, sertraline, neo doxazosin, gabapentin, and azithromycin.
These molecules cover medical needs in areas such as schizophrenia, depression, Parkinson's, hypertension, benign prostatic hyperplasia, epilepsy, neuropathic pain and infections. The last five were and are innovative medicines investigated by Pfizer.
explains Pedro Ballesteros, director of the Operations Unit Established Products Pfizer Spain, within which is included Pharmacia Generic, in the current healthcare environment, "it is important to contribute to the National Health System and the generic quality, efficiency and security that come as a biomedical company Pfizer, committed during more than 160 years R & D to provide innovative medical solutions to patients. "
established drugs are drugs that have lost patent exclusivity market or are about to lose. Since 2009, Pfizer has a portfolio of off-patent medicines originated in the company.
Via Europapress
0 comments:
Post a Comment